APVO

Aptevo Therapeutics Inc

$5.24 +6.72%

Recent alerts on APVO

All signals →

News Aptevo Reports 85% Remission in Q2

News Aptevo Therapeutics announces CEO transition, board leadership changes

SEC filing 8-K Filing

Scanner Unusual volume (10.0x average)

News Ambros Therapeutics Launches with $125 Million Series A Financing to Advance Neridronate Through Phase 3 Registrational Program for Complex Regional Pain Syndrome Type 1

Get push alerts for APVO

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS

Download for iOS